CD8A and neoplasm: CXCR3A is expressed on CD8+ cytotoxic T lymphocytes (CTLs), CD4+ helper type-1 T cells (Th1), and natural killer (NK) cells, and is mainly involved in the mobilization of these cells into inflammatory foci and tumor tissues [10,11].